Transgene Announces Presentation of Data on TG1050 Immunotherapy against Chronic Hepatitis B and Provides Update on its Joint Venture with Tasly Pharmaceuticals in China

Business Wire
Transgene Announces Presentation of Data on TG1050 Immunotherapy against Chronic Hepatitis B and Provides Update on its Joint Venture with Tasly Pharmaceuticals in China
 
View Comments (0)